ArticleRheumatology and therapy2026

Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL Study.

Rieke Alten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.